[1]金露,周丹微,谢日禧,等.督灸防治脾肾阳虚型老年低骨量患者40例疗效评价[J].中国中医骨伤科杂志,2025,33(05):85-88.[doi:10.20085/j.cnki.issn1005-0205.250518]
　JIN Lu,ZHOU Danwei,XIE Rixi,et al.Effect of Du Moxibustion in the Prevention and Treatment of 40 Cases of Elderly Patients with Low Bone Mass of Spleen and Kidney Yang Deficiency Type[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2025,33(05):85-88.[doi:10.20085/j.cnki.issn1005-0205.250518]
点击复制

督灸防治脾肾阳虚型老年低骨量患者40例疗效评价()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第33卷
期数:
2025年05期
页码:
85-88
栏目:
临床报道
出版日期:
2025-05-05

文章信息/Info

Title:
Effect of Du Moxibustion in the Prevention and Treatment of 40 Cases of Elderly Patients with Low Bone Mass of Spleen and Kidney Yang Deficiency Type
文章编号:
1005-0205(2025)05-0085-04
作者:
金露1; 周丹微1; 谢日禧1; 董凡1; 常乐1; 李洁1; 李海勇1; 顾小琼1△
1苏州市中西医结合医院(江苏 苏州,215101)
Author(s):
JIN Lu1; ZHOU Danwei1; XIE Rixi1; DONG Fan1; CHANG Le1; LI Jie1; LI Haiyong2; GU Xiaoqiong1△
1Suzhou Hospital of Integrated Chinese and Western Medicine,Suzhou 215101,Jiangsu China.
关键词:
督灸;  老年低骨量;  骨密度;  脾肾阳虚;  疗效评价
Keywords:
Du moxibustion;  low bone mass in the elderly;  bone mineral density;  spleen and kidney Yang deficiency;  efficacy evaluation
分类号:
R274.39
DOI:
10.20085/j.cnki.issn1005-0205.250518
文献标志码:
B
摘要:
目的:观察督灸在治疗脾肾阳虚型老年低骨量患者中的临床疗效及安全性。方法:将40例脾肾阳虚型老年低骨量患者,应用督灸干预3个月后进行疗效评价,主要观察指标包括非优势侧桡骨远端1/3的骨密度(BMD)、腰背部疼痛评分、骨代谢标志物(Ⅰ型前胶原氨基端前肽(PINP)、骨特异性碱性磷酸酶(B-ALP)、β胶原降解产物(β-CTX))及其安全性。结果:督灸治疗脾肾阳虚型老年低骨量的有效率为92.5%。在接受督灸治疗后,患者骨代谢标志物Ⅰ型前胶原氨基端前肽及骨特异性碱性磷酸酶水平呈现上升态势,与治疗前相比差异有统计学意义(P<0.05); 视觉模拟量表(VAS)评分有所下降,相较于治疗前差异有统计学意义(P<0.05); 骨密度较前有所升高,但差异无统计学意义(P>0.05); 骨代谢标志物Ⅰ型胶原羧基端肽CTX水平变化差异无统计学意义(P>0.05)。不良反应发生率为5%(2/40)。结论:督灸可缓解脾肾阳虚型老年低骨量患者的临床症状,可激活成骨代谢活性、增加骨形成。
Abstract:
Objective:To observe the clinical efficacy and safety of Du moxibustion in the treatment of elderly patients with low bone mass of spleen and kidney Yang deficiency.Methods:40 elderly patients with low bone mass of spleen-kidney Yang deficiency type were treated with Du moxibustion for 3 months.The curative effect was evaluated.The bone mineral density(BMD),low back pain score,bone metabolism markers(type Ⅰ procollagen amino-terminal propeptide(PINP),bone-specific alkaline phosphatase(B-ALP),β-collagen degradation product(β-CTX))of the non-dominant side of the distal 1/3 of the radius were evaluated,and its safety was evaluated.Results:The effective rate of Du moxibustion in the treatment of low bone mass in the elderly with spleen and kidney Yang deficiency was 92.5%.After receiving Du moxibustion treatment,the BMD of the patients was higher than before,but the difference was not statistically significant.The levels of bone metabolic markers PINP and B-ALP showed an upward trend,which were significantly different from those before treatment(P<0.05).At the same time,the visual analogue scale(VAS)score decreased,and the difference was also significant compared with that before treatment(P<0.05).The incidence of adverse reactions was 5%(2/40).Conclusion:Du moxibustion can relieve the clinical symptoms of elderly patients with low bone mass of spleen and kidney Yang deficiency type,activate the activity of osteogenic metabolism and increase bone formation.

参考文献/References:

[1] BIJLSMA A Y,MESKERS C G M,WESTENDORP R G J,et al.Chronology of age-related disease definitions:osteoporosis and sarcopenia[J].Ageing Res Rev,2012,11(2):320-324.
[2] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2022)[J].中华骨质疏松和骨矿盐疾病杂志,2022,15(6):573-611.
[3] 史晓林,刘康.老年性骨质疏松症中西医结合诊疗指南[J].中国骨质疏松杂志,2024,30(7):937-946.
[4] 杨静,田雪梅,王海东,等.“肾主骨”理论辨治强直性脊柱炎继发骨质疏松症[J].中国骨质疏松杂志,2024,30(4):556-559.
[5] 《中国老年骨质疏松症诊疗指南(2023)》工作组,中国老年学和老年医学学会骨质疏松分会,中国医疗保健国际交流促进会骨质疏松病学分会,等,中国老年骨质疏松症诊疗指南(2023)[J].中华骨与关节外科杂志,2023,16(10):865-885.
[6] 中国老年学和老年医学学会骨质疏松分会中医药专家委员会.中医药防治原发性骨质疏松症专家共识(2020)[J].中国骨质疏松杂志,2020,26(12):1717-1725.
[7] 康胜,杨鸫祥,敬一夫,等.从督脉论治骨质疏松症的理论依据和临床研究进展[J].中华中医药学刊,2019,37(5):1228-1230.
[8] 罗婉榕,赵翊,马浇,等.甘肃中老年人膳食质量与骨量关系的研究[J].西安交通大学学报(医学版),2023,44(3):481-488.
[9] 国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:356-360.
[10] 陈文辉,蒋云霞,李双蕾,等.壮骨方煮散对脾肾两虚夹瘀型绝经后低骨量人群的防治疗效评价[J].中华中医药杂志,2021,36(3):1556-1559.
[11] XUN J Q,LI C,LIU M L.Serum exosomes from young rats improve the reduced osteogenic differentiation of BMSCs in aged rats with osteoporosis after fatigue loading in vivo[J].Stem Cell Res Ther,2021,12(1):424.
[12] YUAN Y H,DUAN R M,WU B L.Gene expression profiles and bioinformatics analysis of insulin-like growth factor-1 promotion of osteogenic differentiation[J].Mol Genet Genomic Med,2019,7(10):e00921.
[13] 邓聪,刘航,李子勇,等.扶正强督灸法对绝经后骨质疏松的骨质代谢及其相关内分泌激素的调节作用[J].上海针灸杂志,2018,37(7):801-803.
[14] 赵雪丹,向茜,杨晶晶,等.AMPK通路在骨代谢中调节作用的研究进展[J].中国骨质疏松杂志,2021,27(7):1088-1092.
[15] YAN Y,TAN B,FU F Y,et al.Exercise vs conventional treatment for treatment of primary osteoporosis:a systematic review and meta-analysis of randomized controlled trials[J].Orthop Surg,2021,13(5):1474-1487.
[16] 夏丽颖.中药治疗原发性骨质疏松作用机制研究进展[J].上海中医药大学学报,2017,31(2):95-98.
[17] 黄晓雄,陈维凯,刘滔,等.低氧预处理改善去卵巢大鼠骨髓间充质干细胞的成骨分化潜能[J].中国组织工程研究,2022,26(13):2034-2039.

备注/Memo

备注/Memo:
基金项目:苏州市临床重点病种诊疗技术专项项目(LCZX202344)
苏州市科技发展计划项目(SKYD2023028)
△通信作者 E-mail:fsd9345@163.com
更新日期/Last Update: 2025-05-15